Manuscripts can be submitted by sending text, tables, figures and documents required below by e-mail to submission@onehealthmycology.org. Questions can be asked immediately via this e-mail address. Manuscripts will be verified for completeness, plagiarism and AI-contributions; authors receive confirmation and manuscript number within a week.

Original papers

These are original research articles that report new experiments or provide substantial amount of new information in the field of human and veterinary mycology. Article organization into introduction, methods, results, and discussion is not mandatory. Author may apply different organization depending on the nature of the article and the topic discussed. If articles prepared in IMRaD format, see manuscript check list.

Reviews

Review articles are meant to provide a comprehensive overview of a particular topic, evaluate the available literature, and indicate the future direction of research related to the topic. Authors who wish to write review article are advised to contact the editor before submission. Systematic reviews and meta-analyses should submit a completed PRISMA 2020 checklist and flow diagram where applicable. Narrative reviews can be accepted. Papers will be categorized as ‘Research’, ‘Review’, ‘Education’, ‘Comment’, ‘Report’, ‘Politics’ or any other category that is judged appropriate.

Case reports

Human or animal cases concerning novel species, new and emerging clinical fungi, or unique clinical presentations can be submitted. Case presentation should include detailed demographic and clinical information, diagnosis, treatment, intervention, and outcome.  All reports will undergo pre-submission review and within a few weeks the authors will receive feedback from the journal to re-submit the case or a proposal for combining the case with other submitted case series. At this stage, please submit only the case presentation and figures/illustrations embedded in the text. Note, the journal requires molecular identification of the isolated fungi. Submit the sequences of single or multiple genes/markers along with the case presentation for quality control.
Case reports should follow the CARE reporting guideline where applicable, and authors may be asked to submit a completed CARE checklist. Case reports, clinical images, patient photographs, pedigrees, genetic information, or any potentially identifiable patient information require written consent for publication from the patient, parent or legal guardian, next of kin, or legally authorized representative, unless this requirement has been formally waived by an ethics committee or institutional review board. Authors must remove unnecessary identifying details. However, complete anonymity cannot always be guaranteed, particularly in rare diseases, unusual infections, genetic information, or highly specific clinical histories. Authors may be required to submit the Patient Consent for Publication Form before acceptance or publication.

Meeting reports

Abstracts presented at relevant meetings, preceded by a general introduction on the results of the meeting, can be published by the meeting organizers. Abstracts each are listed with the submitters / presenters as author(s).

Politics

Articles on measures to be taken, government regulations, and other human actions with impact on life and environment can be published. The journal provides a forum for diverse and opposing viewpoints while maintaining a commitment to editorial neutrality.

Comments

Personal opinions on particular conditions or developments are welcome. The responsibility for the text remains with the author. The journal provides a forum for diverse and opposing viewpoints while maintaining a commitment to editorial neutrality.

Language: Use English language.
Files: Use Microsoft Word unless indicated otherwise.
Text: Use any standard font, size 12, double-spaced, continuous line numbers, and include page numbers. Write Latin words, genera and species names in italic.
Manuscript length: There is no limitation regarding the number of words, figures, tables, and supplementary materials. However, authors are encouraged to keep the text as concise as possible.
Abbreviations: Define when first time they appear followed by the abbreviation in parentheses. Abbreviations can be listed on the title page. Explanatory text boxes are allowed.

Authors must submit the relevant forms and reporting checklists together with the manuscript. The relevant forms and checklists are available on the Author Forms page. Please provide ORCID and email addresses for all authors.

Author declaration form

Required for all submissions. The corresponding author must confirm that all authors have approved the submission, that the manuscript is original, that it is not under consideration elsewhere, and that all required declarations are complete.

Conflict of interest disclosure form

Required for all submissions. Each author should complete a conflict of interest disclosure form. Authors may use the ICMJE Disclosure Form or the journal form.
Download: ICMJE Disclosure Form

Manuscript submission checklist

Required for all submissions. Authors should complete this checklist before submission to ensure that all required manuscript sections, declarations, figures, tables, supplementary files, and reporting checklists are included.

Patient consent for publication form

Required where applicable. Required for case reports, clinical images, patient photographs, pedigrees, genetic information, or any potentially identifiable patient information.

Ethics approval / human participants declaration form

Required where applicable. Required for studies involving human participants, human samples, medical records, clinical data, or identifiable patient information.

CARE checklist

Required where applicable. Required for clinical case reports.
Download: CARE Checklist

STROBE checklist

Required where applicable. Required for observational studies, including cohort, case-control, and cross-sectional studies.
Download: STROBE Checklist

PRISMA 2020 checklist

Required where applicable. Required for systematic reviews and meta-analyses. Authors should also submit a PRISMA flow diagram where applicable.
Download: PRISMA 2020 Checklist

ARRIVE author checklist

Required where applicable. Required for animal research.
Download: ARRIVE Author Checklist

STARD checklist

Required where applicable. Required for diagnostic accuracy studies.
Download: STARD Checklist

Data and sequence availability checklist

Required where applicable. Required when the manuscript includes newly generated sequence data, genomic data, datasets, software, code, or phylogenetic analyses.

Guidance links

CRediT author contribution taxonomy: Authors are encouraged to describe author contributions using the CRediT taxonomy where appropriate (https://credit.niso.org/).
COPE core practices: One Health Mycology refers to COPE Core Practices when handling publication ethics concerns, corrections, retractions, appeals, and complaints (https://publicationethics.org/guidance/guideline/principles-transparency-and-best-practice-scholarly-publishing).
COPE retraction guidelines: Editors may refer to COPE Retraction Guidelines when handling corrections, retractions, and expressions of concern (https://publicationethics.org/guidance/guideline/retraction-guidelines).

Cover letter

The cover letter should explain concisely the significance of the research findings and the relevance of the manuscript to the journal’s scope. The letter will only be available for the editor and should include the following statements: the manuscript has not been submitted, published or under consideration for publication in any other journal, and the authors have agreed and approved the submission of the manuscript.

Manuscript body

Title: The title must be clear, concise, informative, and specific. Avoid the use of abbreviations and formulae. There is no word limit for the title.
Author information: The name(s) of the author(s), their affiliation(s) including institution, (department), city, and country. ORCID if available. Indicate the affiliations with a lowercase superscript letter after the author’s name and in front of the appropriate address. The corresponding author(s) should be marked with an asterisk in the author list.
Corresponding author: Email address and full postal address of the corresponding author(s). A maximum of two authors can be designated. 
Abstract: Use unstructured abstract to briefly describe aims, methods, results and the conclusion of the project. Avoid uncommon abbreviation and citation in the abstract. You may use unlimited number of words.
Keywords: One Health Mycology requires a minimum of 3 and a maximum of 8 keywords.
Introduction: Provide succinct overview of the studied topic,  state the overall aim of the work, and cite relevant, up to date literature.
Materials and methods: Describe comprehensively how the experiment was performed to allow reproduction of the work. Provide in details full protocols, suppliers of any material or equipment’s, software, and statistical analysis used. For published methods, cited the article where it was published and indicate if there are any modifications occur. Research conducted on human or animal requires an ethical approval section: include the approval number, the committee or review board who granted the approval.
For studies involving human participants, human samples, medical records, clinical data, or identifiable patient information, authors must state whether informed consent was obtained. If consent was waived, the manuscript must state the name of the ethics committee or institutional review board that granted the waiver.
For case reports, clinical images, patient photographs, pedigrees, genetic information, or any potentially identifiable patient information, written consent for publication must be obtained unless formally waived by an ethics committee or institutional review board.
Research involving animals must include the name of the approving animal ethics committee or authority and the approval number where applicable. If approval was not required, authors must explain why. Animal research should follow ARRIVE reporting guidelines where applicable.
Studies involving pathogenic fungi, clinical isolates, fungal cultures, environmental sampling, field sampling, genetic resources, or potentially regulated biological materials must comply with relevant institutional, national, and international biosafety, sampling, transport, and access regulations where applicable.
Results: Use text, tables, figures, or graphics to describe the results of your research. Present and interpret the results in a logical and organized manner under relevant subheadings. Large tables or raw data can be submitted as supplementary material.
Discussion: Discussion may be combined with the results section. Discus the results in constructive way, compared them to previous studies on the topic, and describe limitations or strength of the findings. Recommendations and future research directions can be discussed as well.
Acknowledgements: This section may be added to acknowledge the contributions of individuals who do not meet the recommended criteria for authorship and agreed to be listed in the acknowledgment. Funding agencies, grant numbers, institutions may be acknowledged as well.
References: Cite references within the text using the author’s last name and year of publication in parentheses. Ensure that the reference list is alphabetized by the last name of the first author. List all references at the end of your manuscript in the format exemplified below. Ensure that listed references are cited in the text and in the order they appear. Reference list may include only published or accepted articles or preprint with available DOI or URL. Submitted or unpublished articles or personal communications can be cited within the text only.

See the examples below:

Published articles: Last name initial (first three authors, et al). Year of publication. Title article. Abbreviated journal title. Volume:page. (doi if available).

Rodrigues ML, Nosanchuk JD. (2020). Fungal diseases as neglected pathogens: A wake-up call to public health officials. PLoS Negl Trop Dis. 14:e0007964. doi: 10.1371/journal.pntd.0007964.

Books: Last name initial (first three authors, et al). Year of publication. Book title. Edition. Place of publication: publisher.

de Hoog GS, Guarro J, Gené J, et al. (2020). Atlas of Clinical Fungi, 4th ed. Foundation Atlas of Clinical Fungi, Hilversum.

Book chapters: Last name initial(s) (first three authors, et al). Year of publication. Title of the chapter. In: Last name initial(editors), (eds). Book title. Place of publication: publisher; page numbers.

de Hoog GS, Ahmed S, Danesi P, et al. (2018). Distribution of pathogens and outbreak fungi in the fungal kingdom. In: Seyedmousavi S, de Hoog GS, Guillot J, Verweij PE (eds). Emerging and epizootic fungal infections in animals. Springer, Dordrecht, pp. 3–16.

Website: Publishing body. Title. [Internet]. Available from: URL. [Date of access].

World Health Organization (WHO). Global tuberculosis report 2020. [Internet]. Available from: https://www.who.int/publications/i/item/9789240013131. [Accessed 01-04-2023].

Tables

Submit tables in separate files, either in Microsoft Excel or Word. Label the tables in ascending order starting from “Table 1”. Place the caption above each table and legends or footnotes below the table. Make sure that every table is cited with the same number within the text.

Figures

Give every figure a number according to the order they appear in the text and make sure that the figures are cited in the text. Submit figure files in TIF or EPS format with a minimum resolution of 300 dpi and the following dimensions: minimum width 7 cm, maximum width 18 cm, minimum height 7 cm, and maximum height 22 cm. For multi-panel figures, if you use photoshop, submit the psd file with unflattened layers. You may submit separate pictures and the editorial office will assist in the preparation of final figure. Font size of any text within the figures must be a minimum of 10 point. Phylogenetic trees can be submitted as PDF or Adobe Illustrator files.

Statements

Conflict of interest: Authors should disclose any potential conflicts of interest that could influence the work. If there is nothing to declare, state this as well. Each author should complete a Conflict of Interest Disclosure Form. Authors may use the ICMJE Disclosure Form or the journal’s own disclosure form. The completed disclosure form should be submitted with the manuscript or provided upon request by the editorial office.
Author contributions: Describe the contribution of every author to the research project, following the CRediT taxonomy. All listed authors must have made substantial contributions to the work and must approve the final submitted version. Guest authorship, ghost authorship, and honorary authorship are not acceptable. Any change in authorship after submission, including addition, removal, or change in author order, requires written agreement from all authors and approval by the editorial office.
Taxonomy and nomenclature: For current and recommended names of clinically important fungi, please refer to the Atlas of Clinical Fungi. Research descriping taxonomic novelties should follow the guideline of International Code of Nomenclature for algae, fungi, and plants. Authors must provide a full description of the new taxa, reference collection number of ex-type strain of new species, and accession numbers of the new names deposited in one of the repositories accepted by Nomenclature Committee for Fungi (NCF).
Funding information: Describe the funding sources that supported the research project, including the names of funding bodies and grant numbers. If the authors didn’t receive funding for the work, add the statement “This work received no specific grant from any funding agency.”
Data availability: Authors should include a data availability statement describing where data supporting the findings can be accessed. If data are not publicly available, authors should explain why.
Use of artificial intelligence tools: If artificial intelligence tools were used for language editing, data processing, image processing, analysis, or manuscript preparation, authors must disclose the tool used and describe its role. Authors remain fully responsible for the accuracy, originality, integrity, and ethical compliance of the submitted work. AI tools cannot be listed as authors.
Research misconduct and publication malpractice: Plagiarism, duplicate publication, redundant publication, data fabrication, data falsification, inappropriate image manipulation, peer-review manipulation, citation manipulation, undisclosed conflicts of interest, and unethical research practices are not acceptable. The journal may screen manuscripts for plagiarism, duplicate publication, image manipulation, and AI-assisted content where appropriate.

Sequences

Deposit new sequence data in one of the reference repositories such as GenBank, EMBL, DDBJ, PIR, Uniprot or PRIDE and include the accession number in the manuscript. Sequences of the ITS must be a minimum of 400 bp long. The editor might request adding sequences or alignment to the submission before the reviewing the manuscript. Authors may be asked to provide sequence files, alignments, phylogenetic trees, metadata, software, scripts, or other supporting files during editorial assessment or peer review. Newly generated sequence data must be deposited before final publication, and accession numbers must be included in the final manuscript.